Mitral valve replacement with the pulmonary autograft: Ross II procedure with Kabanni modification.
We report our experience with pulmonary autograft replacement of the mitral valve in eight patients. Hospital mortality of 0% was reported, and there has been one autograft failure requiring replacement (mean follow-up 12 +/- 6 months). We also review the world's experience with this technique. Mitral valve replacement with a pulmonary autograft (Ross II) is safe, reproducible, and possible warranted for selected patients.